FDA approves Amgen’s Wezlana biosimilar Wezlana is used to treat multiple inflammatory diseases. Theravance, Mylan settle patent litigation with Teva over YupelriTeva has been granted a royalty-free, non-exclusive license to market generic Yupelri in the United States on or after April 23, 2039. NACDS’ health, wellness initiatives take center stage at 2023 Milken Institute Future of Health Summit NACDS’ initiatives regarding health and wellness were on display at the 2023 Milken Institute Future of Health Summit. Phathom Pharmaceuticals receives FDA nod for Voquezna Voquezna is a new treatment for adults for the healing and maintenance of all grades of erosive esophagitis. Alembic debuts 2 generics Alembic is introducing generic chlorpromazine hydrochloride tablets and generic Combigan. Pharmacy orgs laud bipartisan Senate Finance Committee vote to advance PBM reforms in Medicare, Medicaid The Senate Finance Committee advanced the legislation on a strong bipartisan vote of 26-0, with one ‘present.’ Walgreens reportedly makes leadership changes, trims corporate staff Luke Rauch and Robert Tompkins are departing Walgreens, amid around 267 reported corporate layoffs. Somerset intros generic calcium gluconate Calcium gluconate is an essential medicine used in the treatment of acute symptomatic hypocalcemia in pediatric and adult patients. Eli Lilly obtains FDA OK for Omvoh Omvoh is a treatment for adults with moderate to severe ulcerative colitis. FDA reviewing AstraZeneca’s application for self-administration of Flumist Flumist has the potential to be the only self-administered flu vaccine. First Previous 88 89 90 91 92 Next Last
